The best ad blockers are unfortunately very necessary to survive on the modern internet. It doesn't matter which sites you browse, there's the risk of being harassed by pop-ups, tracker cookies ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

Licensed Professional Counselor Yvette Bunting-Watts puts it simply: “No one enjoys feeling the lack of joy.” Bunting-Watts, knows the topic of mental health well, as she is the founder and CEO of ...

The Google Mobile Ads SDK is the latest generation in Google mobile advertising featuring refined ad formats and streamlined APIs for access to mobile ad networks and advertising solutions. The SDK ...

In January, 2025, J&J’s nasal spray Spravato secured a label expansion from the FDA for use as a single agent in adults with major depressive disorder (who were not responsive to two oral ...

Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...

Transcranial Magnetic Stimulation (TMS), and Spravato®. This acquisition, which is still subject to financial audits and definitive agreements, is expected to enhance HOPE’s revenue projections ...